Feb 01, 2021 7:30am EST Algernon Pharmaceuticals Launches Stroke Treatment Clinical Research Program with Psychedelic Drug DMT “The Spirit Molecule”
Jan 19, 2021 11:59am EST Algernon Pharmaceuticals Provides Reminder on Expiry Date of Accelerated Warrants
Jan 19, 2021 8:03am EST Algernon Pharmaceuticals Receives Green Light from DSMB to Conduct Phase 3 Study of Ifenprodil for COVID-19
Jan 11, 2021 8:00am EST Algernon Highlights New Independent Research Review Identifying Ifenprodil as a Potential COVID-19 Treatment
Dec 24, 2020 11:42am EST Algernon Pharmaceuticals Announces Last Patient Out in Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19
Dec 21, 2020 8:00am EST Algernon CEO and CSO to Discuss COVID-19 Study Interim Data Results Featured on Streetsmart Live! Webcast
